Add-on Acquisition • Life Science

Bausch Health Acquires Tecnofarma S.A. de C.V.

On July 29, 2009, Bausch Health acquired life science company Tecnofarma S.A. de C.V.

Acquisition Context
  • This is Bausch Health’s 4th transaction in the Life Science sector.
  • This is Bausch Health’s 1st transaction in Mexico.

Explore All 3111 Add-on Acquisition Life Science Deals - Search the Database Free


M&A Deal Summary

Date July 29, 2009
Target Tecnofarma S.A. de C.V.
Sector Life Science
Buyer(s) Bausch Health
Deal Type Add-on Acquisition

Target Company

Tecnofarma S.A. de C.V.

Iztacalco, Mexico
Tecnofarma is a producer of generic pharmaceuticals to the government and private label markets.
Explore More Deals

Browse All 215,262 Deals

FILTER BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Search Free

Buyer Overview 1

Buyer

Bausch Health

Laval, Quebec, Canada

Category Company
Sector Life Science
Employees20,270
Revenue 9.6B USD (2024)
DESCRIPTION

Bausch Health is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology, neurology, and branded generics. Bausch Health is based in Laval, Quebec.


Deal Context for Buyer #
Overall 4 of 36
Sector: Life Science 4 of 22
Type: Add-on Acquisition 4 of 26
Country: Mexico 1 of 1
Year: 2009 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2008-12-10 Dow Pharmaceutical Sciences

Petaluma, California, United States

Developer, manufacturer and marketer as well as formulator of topical therapies focused on the dermatology market.

Buy $285M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2010-04-28 VitalScience

Toronto, Ontario, Canada

VitalScience Corp. is a over-the-counter (OTC) dermatology company located in Toronto, Ontario. VitalScience is an independent Canadian corporation dedicated to providing innovative, effective, unique, products and services to the Canadian market.

Buy CA$11M